Minerva Neurosciences
NERV
67 hedge funds and large institutions have $343M invested in Minerva Neurosciences in 2016 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 10 closing their positions.
230% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 10
53% more capital invested
Capital invested by funds: $225M → $343M (+$118M)
40% more first-time investments, than exits
New positions opened: 14 | Existing positions closed: 10
6% more funds holding
Funds holding: 63 → 67 (+4)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$7.77M |
| 2 |
HCMT
Highland Capital Management (Texas)
Dallas,
Texas
|
+$5.52M |
| 3 |
IHM
Iguana Healthcare Management
New York
|
+$3.94M |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$3.64M |
| 5 |
O
OrbiMed
New York
|
+$2.85M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
-$3.03M |
| 2 |
VC
Vivo Capital
Palo Alto,
California
|
-$2.04M |
| 3 |
NC
Nexthera Capital
New York
|
-$1.09M |
| 4 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$570K |
| 5 |
D.E. Shaw & Co
New York
|
-$498K |
NERV Hedge Fund Activity: Q3 2016 in Review
67 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2016, worth a combined $343M — up 53% from $225M a quarter earlier.
Buyers outnumbered sellers: 14 funds opened new NERV positions and 10 closed out — a net gain of 4 holders — while 33 added to existing stakes and 10 trimmed.
The largest buyer was T. Rowe Price Associates, opening a new position worth an estimated $7.77M. The largest seller was Baker Bros. Advisors, cutting an estimated $3.03M.
- 67 institutional investors held Minerva Neurosciences (NERV) as of Q3 2016, up from 63 in Q2 2016.
- Funds reported $343M of Minerva Neurosciences stock for Q3 2016, up 53% quarter-over-quarter.
- 14 funds opened new Minerva Neurosciences positions in Q3 2016 and 10 closed out, a net change of +4 holders.
- The largest Minerva Neurosciences buyer in Q3 2016 was T. Rowe Price Associates, an estimated $7.77M added.
- The largest Minerva Neurosciences seller in Q3 2016 was Baker Bros. Advisors, an estimated $3.03M sold.
Based on aggregated 13F filings for Q3 2016.